Developer docs
API playgroundTry for free, no card

Search company profiles

Curexo

Full company profile

uuid00293co

Namestring
Curexo
Legal namestring
CUREXO Inc.
Websiteurl
curexo.com
Company typeenum
Public
Founded yearint
2017
Descriptiontext

Curexo Inc. (ticker: 060280 KOSDAQ) is a South Korea-based medical robotics company that designs, manufactures, and sells surgical and rehabilitation robot systems to hospitals and medical institutions. The company was established in 2017 when it acquired Hyundai Heavy Industries' medical business division and built core technology on top of assets acquired from U.S.-based ISS, positioning itself as Korea's only pure-play medical robotics company. Its product portfolio consists of CUVIS-joint (a fully automated orthopedic surgery robot for knee and now hip arthroplasty with CT-based 3D planning and autonomous bone cutting), CUVIS-spine (a navigation-guided spinal surgery robot for pedicle screw placement), and the MorningWalk / MorningWalk S200 end-effector gait rehabilitation robot. The systems incorporate proprietary AI-based surgical planning, real-time optical tracking, and open-platform compatibility with implants from multiple manufacturers.

Curexo generates revenue primarily through one-time capital equipment sales to hospitals, supplemented by recurring revenue from surgical instruments and consumables tied to the installed base, plus installation, training, and after-sales service contracts. Its go-to-market combines direct enterprise field sales (especially in Korea and key international markets) with regional distribution partners, including Permedica for Italy and Morocco, ARTIMEDICA for Mexico, Droguepar S.A. for Paraguay, M&M Brazil for Latin America, OrthoHouse for Egypt, Harmonic Bionics and AEGIS Spine in the United States, CG Bio for Korea spine distribution, and Fourier Intelligence for global MorningWalk distribution across 50+ countries. Demand generation relies heavily on major orthopedic and rehabilitation conferences (AAOS, KIMES, JARM, NASS, ITC) and live surgery demonstrations at partner hospitals.

In 2025, Curexo shipped 88 medical robots (73 CUVIS-joint, 8 MorningWalk, 4 In Motion, 3 CUVIS-spine), up 41.9% from 62 units in 2022, and reported revenue growth of approximately 37% in 2025 driven by approvals and unit expansion. Its regulatory footprint covers Korean MFDS, US FDA, European CE MDR, Japanese PMDA, Indian CDSCO, and Mexican COFEPRIS, with 2026 marking the entry into the U.S. and broader European markets. Curexo is publicly listed on KOSDAQ with no disclosed venture or private equity funding rounds and no parent company.

Short descriptiontext

Curexo Inc. (KOSDAQ: 060280) is a South Korea-based medical robotics company that designs and sells fully automated orthopedic surgical robots (CUVIS-joint, CUVIS-spine) and the MorningWalk gait rehabilitation robot to hospitals and medical institutions across Asia, Europe, the Americas, the Middle East, and Africa.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic surgical robots, spine surgery robots, gait rehabilitation robots, robotic joint replacement, medical robotics systems
Industry3 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Robotics Systems
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Robot Hardware Sales
TypeHardware Sales
Description

Sale of surgical robots (CUVIS-joint, CUVIS-spine) and rehabilitation robots (Morning Walk) as capital equipment to hospitals and medical institutions. The company has supplied 88 units in 2023 and targets 100+ units annually.

curexo.com
2Consumables and Surgical Instruments
TypeHardware Sales
Description

Sales of surgical instruments and consumables used during robotic surgeries, providing recurring revenue from installed base

curexo.com
3Service and Technical Support
TypeProfessional Services
Description

Installation, training, and after-sales service (A/S) provided through technical support teams, including both domestic and international clinical/technical support

curexo.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels8 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Pricing details3 tiers
1CUVIS-joint (Artificial Joint Surgery Robot) - enterprise pricing
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Capital equipment pricing for hospitals; specific price points not publicly disclosed

curexo.com
2CUVIS-spine (Spine Surgery Robot) - enterprise pricing
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Capital equipment pricing; quote-based for institutional buyers

curexo.com
3Morning Walk (Gait Rehabilitation Robot) - enterprise pricing
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Capital equipment with potential recurring consumables; South Korea health insurance coverage may apply for rehabilitation services

curexo.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1CUVIS-joint
Description

Fully automated robotic system for joint replacement surgery (knee and hip arthroplasty) with AI-based surgical planning and precision bone cutting.

curexo.com
+2 more records
Core offering1 text field

Curexo designs, manufactures, and sells medical robotics systems for orthopedic surgery, spine surgery, and lower-limb rehabilitation. Its product portfolio includes the CUVIS-joint fully automated joint replacement surgery robot (knee and hip), the CUVIS-spine spinal surgery robot for pedicle screw guidance, and the MorningWalk end-effector gait rehabilitation robot. The company supplies these robots as capital equipment to hospitals and medical institutions globally, supported by installation, training, and after-sales services along with recurring surgical instrument and consumable sales.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • CUVIS-joint cumulative surgeries: 43,000+ cases across 9+ countries
+4 more records
Product overview1 text field

Curexo is a medical robotics company specializing in surgical and rehabilitation robots. The product portfolio consists of two surgical robot systems and one rehabilitation robot: CUVIS-joint (fully automated joint replacement surgery robot), CUVIS-spine (spinal surgery robot with pedicle screw guidance), and MorningWalk/MorningWalk S200 (end-effector gait rehabilitation robot). CUVIS-joint operates as an open-platform system compatible with multiple implant manufacturers, while CUVIS-spine and MorningWalk serve distinct clinical applications in spine surgery and rehabilitation, respectively. The company offers products covering the full patient care continuum from surgical intervention to recovery.

Product and service3 records
1CUVIS-joint
CategorySurgical Robot
Description

A fully automated robotic system for joint replacement surgery that analyzes patient CT scans in 3D to establish optimized surgical plans and uses a multi-joint robotic arm to precisely cut bone during surgery. Features an open-platform architecture compatible with implants from multiple manufacturers and supports patient-specific procedures. Used by orthopedic surgeons and hospitals performing total knee, unicompartmental knee, and total hip arthroplasty.

2CUVIS-spine
CategorySurgical Robot
Description

A spinal surgery robot system that provides precise guidance for pedicle screw insertion through preoperative image-based planning and real-time patient position tracking. Combines robotic accuracy with conventional surgical approaches to reduce surgical variability and radiation exposure. Used by neurosurgical and orthopedic spine surgery departments in hospitals.

3MorningWalk
CategoryRehabilitation Robot
Description

A footplate-based end-effector gait rehabilitation robot designed for patients with lower-limb paralysis or gait impairments, including stroke, spinal cord injury, Parkinson's disease, and post-surgery recovery. Offers shorter setup times and varied gait training patterns compared to exoskeleton systems, and includes propulsion feedback training for active gait training. Designed for both pediatric and adult populations. Used by rehabilitation hospitals and physical therapy centers.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
1Droguepar S.A.
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-19
Description

Paraguayan medical device company partnered for CUVIS-joint supply agreement, marking Curexo's entry into Paraguay market and expansion of Latin American footprint.

curexo.com
2ARTIMEDICA
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-01
Description

Mexican medical device company collaborating with Curexo for local sales and marketing of CUVIS-spine following COFEPRIS regulatory approval.

curexo.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-30
Description

Italian orthopedic implant company (founded 1986) serves as distribution partner for CUVIS-joint in Italy and Morocco. Joint surgery demonstration at FM6SS Morocco showcased synergy between Curexo's bone cutting and Permedica's implants. Open platform strategy enables collaboration across implant manufacturers.

4Korean Trade-Investment Promotion Agency (KOTRA)
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2026-04-01
Description

KOTRA organized Korea-India Business Partnership Forum where Curexo participated to expand Indian market network. Forum held during bilateral summit schedule in New Delhi.

curexo.com
5M&M Brazil
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-01
Description

Local partner for participation in CBCJ 2026 (Brazilian Knee Surgery Congress) in São Paulo, showcasing CUVIS-joint at booth #12.

curexo.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-27
Description

Korean bio-regenerative medicine company signed exclusive domestic distribution agreement for CUVIS-spine. Partnership aims to expand in domestic and international spine surgery markets through robot-navigation-based platform.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-12
Description

SPG signed MOU to supply precision actuators for Curexo's medical robots. Partnership aims to localize core components and enhance global competitiveness through custom actuator design, technical exchanges, and joint marketing activities.

8OrthoHouse
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-01
Description

Egyptian partner company participating with Curexo at ITC 2026 (International Trauma Congress) in Dubai for MENA market expansion.

curexo.com
9Indian Subsidiary
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-01
Description

Curexo established Indian subsidiary for direct market presence and local network expansion in India's high-growth medical robotics market.

career.curexo.com
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-04-01
Description

US-based Harmonic Bionics partnered with Curexo to distribute the Morning Walk S200 gait rehabilitation system in the walking assist devices market.

11Think Surgical Inc. (TSI)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Partnership for AAOS 2024 exhibition where CUVIS-joint (US product name: TMAX) was showcased to US market.

career.curexo.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-01-01
Description

Korean robot automation platform company partnered for supply of robot manipulators. Strategic partnership led to purchase agreement for 200 robot manipulators including trial production of CUVIS-joint robot arm prototypes.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-01-01
Description

US spine implant company distributing CUVIS-spine in United States market for spine surgery procedures.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-08-01
Description

Strategic global partnership for distribution of Morning Walk gait rehabilitation robot. Fourier's network spans 50+ countries including Singapore, Malaysia, Thailand, UK, Australia. Also exploring joint technology development for rehabilitation robotics.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Stryker's Mako robotic-arm-assisted surgery system is the dominant robotic joint replacement platform globally, with thousands of installations and the largest US installed base. Directly comparable to CUVIS-joint in TKA/THA, though Stryker operates at vastly larger scale and with proprietary closed-platform integration.

TypeDirect peer
Description

Renishaw's neuromate robotic system targets stereotactic neurosurgery, sharing technological overlap with CUVIS-spine's image-guided pedicle screw placement. Both are precision-guided surgical robotic platforms competing for hospital surgical departments.

TypeBroad incumbent
Description

Intuitive Surgical's da Vinci is the dominant general-surgery robotic platform globally with a vast installed base. While da Vinci does not directly compete in orthopedics, it defines the hospital robotic-surgery procurement landscape that CUVIS-joint and CUVIS-spine compete within.

TypeDirect peer
Description

Globus Medical's ExcelsiusGPS is a leading robotic spine surgery platform with strong US hospital penetration. Directly comparable to CUVIS-spine, with similar navigation-and-arm integration approach; Globus pairs robotics with its own spine implant portfolio.

TypeDirect peer
Description

Medtronic's Mazor robotic guidance system is a market leader in spine robotics, directly competing with Curexo's CUVIS-spine for hospital spine surgery accounts. Medtronic also operates Hugo for general surgery, providing scale and breadth Curexo lacks.

TypeDirect peer
Description

Zimmer Biomet's ROSA robotic system spans knee, hip, and spine indications, directly overlapping with Curexo's CUVIS-joint and CUVIS-spine portfolio. As one of the 'big five' orthopedic players, Zimmer Biomet competes on bundled implants and an established sales network.

TypeEmerging player
Description

Fourier Intelligence is a Chinese rehabilitation robotics company and Curexo's exclusive global distribution partner for Morning Walk. Overlapping product portfolio in gait-rehabilitation robotics makes it both a channel partner and a direct competitor in select end markets.

TypeDirect peer
Description

Smith+Nephew's CORI handheld robotic system targets robotic-assisted knee surgery with a compact, image-free design. Directly comparable to CUVIS-joint in surgical indication and target customer segment, though Smith+Nephew has a much broader orthopedic portfolio and established global salesforce.

9THINK Surgical
TypeDirect peer
Description

THINK Surgical develops open-platform robotic systems for orthopedic surgery — architecturally aligned with Curexo's implant-agnostic CUVIS-joint strategy. Curexo has an existing partnership with TSI for AAOS exhibitions, and the two are direct competitors in open-platform orthopedic robotics.

10Hocoma (rehabilitation robotics)
TypeDirect peer
Description

Hocoma (a DIH Medical company) is a leading developer of robotic and sensor-based rehabilitation devices including gait-training systems. Directly comparable to Curexo's Morning Walk in end-effector gait rehabilitation for stroke and orthopedic patients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Curexo

Medical Robotics Systemscurexo.com

Curexo Inc. (KOSDAQ: 060280) is a South Korea-based medical robotics company that designs and sells fully automated orthopedic surgical robots (CUVIS-joint, CUVIS-spine) and the MorningWalk gait rehabilitation robot to hospitals and medical institutions across Asia, Europe, the Americas, the Middle East, and Africa.

What Curexo does

Curexo Inc. (ticker: 060280 KOSDAQ) is a South Korea-based medical robotics company that designs, manufactures, and sells surgical and rehabilitation robot systems to hospitals and medical institutions. The company was established in 2017 when it acquired Hyundai Heavy Industries' medical business division and built core technology on top of assets acquired from U.S.-based ISS, positioning itself as Korea's only pure-play medical robotics company. Its product portfolio consists of CUVIS-joint (a fully automated orthopedic surgery robot for knee and now hip arthroplasty with CT-based 3D planning and autonomous bone cutting), CUVIS-spine (a navigation-guided spinal surgery robot for pedicle screw placement), and the MorningWalk / MorningWalk S200 end-effector gait rehabilitation robot. The systems incorporate proprietary AI-based surgical planning, real-time optical tracking, and open-platform compatibility with implants from multiple manufacturers.

Curexo generates revenue primarily through one-time capital equipment sales to hospitals, supplemented by recurring revenue from surgical instruments and consumables tied to the installed base, plus installation, training, and after-sales service contracts. Its go-to-market combines direct enterprise field sales (especially in Korea and key international markets) with regional distribution partners, including Permedica for Italy and Morocco, ARTIMEDICA for Mexico, Droguepar S.A. for Paraguay, M&M Brazil for Latin America, OrthoHouse for Egypt, Harmonic Bionics and AEGIS Spine in the United States, CG Bio for Korea spine distribution, and Fourier Intelligence for global MorningWalk distribution across 50+ countries. Demand generation relies heavily on major orthopedic and rehabilitation conferences (AAOS, KIMES, JARM, NASS, ITC) and live surgery demonstrations at partner hospitals.

In 2025, Curexo shipped 88 medical robots (73 CUVIS-joint, 8 MorningWalk, 4 In Motion, 3 CUVIS-spine), up 41.9% from 62 units in 2022, and reported revenue growth of approximately 37% in 2025 driven by approvals and unit expansion. Its regulatory footprint covers Korean MFDS, US FDA, European CE MDR, Japanese PMDA, Indian CDSCO, and Mexican COFEPRIS, with 2026 marking the entry into the U.S. and broader European markets. Curexo is publicly listed on KOSDAQ with no disclosed venture or private equity funding rounds and no parent company.

Curexo firmographics

Firmographics
Name
Curexo
Legal name
CUREXO Inc.
Website
https://curexo.com
Company type
Public
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
Curexo Inc. (KOSDAQ: 060280) is a South Korea-based medical robotics company that designs and sells fully automated orthopedic surgical robots (CUVIS-joint, CUVIS-spine) and the MorningWalk gait rehabilitation robot to hospitals and medical institutions across Asia, Europe, the Americas, the Middle East, and Africa.
Ownership category
akta.pro rank

Curexo industry classification

Industry
Product category
Medical Robotics Systems
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics

Keywords

  • Orthopedic surgical robots
  • Spine surgery robots
  • Gait rehabilitation robots
  • Robotic joint replacement
  • Medical robotics systems

Where Curexo is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices3 records

Markets served

Curexo business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Medical Robot Hardware Sales: Sale of surgical robots (CUVIS-joint, CUVIS-spine) and rehabilitation robots (Morning Walk) as capital equipment to hospitals and medical institutions. The company has supplied 88 units in 2023 and targets 100+ units annually.
  2. Consumables and Surgical Instruments: Sales of surgical instruments and consumables used during robotic surgeries, providing recurring revenue from installed base
  3. Service and Technical Support: Installation, training, and after-sales service (A/S) provided through technical support teams, including both domestic and international clinical/technical support

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractCUVIS-joint (Artificial Joint Surgery Robot) - enterprise pricing
One time/ perpetual licenseMulti-year contractCUVIS-spine (Spine Surgery Robot) - enterprise pricing
One time/ perpetual licenseMulti-year contractMorning Walk (Gait Rehabilitation Robot) - enterprise pricing

Go-to-market motion3 records

Distribution channels8 records

Marketing channels8 records

Curexo product offering

Product offering

Core offering

Curexo designs, manufactures, and sells medical robotics systems for orthopedic surgery, spine surgery, and lower-limb rehabilitation. Its product portfolio includes the CUVIS-joint fully automated joint replacement surgery robot (knee and hip), the CUVIS-spine spinal surgery robot for pedicle screw guidance, and the MorningWalk end-effector gait rehabilitation robot. The company supplies these robots as capital equipment to hospitals and medical institutions globally, supported by installation, training, and after-sales services along with recurring surgical instrument and consumable sales.

Product overview

Curexo is a medical robotics company specializing in surgical and rehabilitation robots. The product portfolio consists of two surgical robot systems and one rehabilitation robot: CUVIS-joint (fully automated joint replacement surgery robot), CUVIS-spine (spinal surgery robot with pedicle screw guidance), and MorningWalk/MorningWalk S200 (end-effector gait rehabilitation robot). CUVIS-joint operates as an open-platform system compatible with multiple implant manufacturers, while CUVIS-spine and MorningWalk serve distinct clinical applications in spine surgery and rehabilitation, respectively. The company offers products covering the full patient care continuum from surgical intervention to recovery.

Differentiator

Problem solved

Functional benefit

Brands

  • CUVIS-joint: Fully automated robotic system for joint replacement surgery (knee and hip arthroplasty) with AI-based surgical planning and precision bone cutting.
  • CUVIS-spine
  • MorningWalk

Products and services

  • CUVIS-joint A fully automated robotic system for joint replacement surgery that analyzes patient CT scans in 3D to establish optimized surgical plans and uses a multi-joint robotic arm to precisely cut bone during surgery. Features an open-platform architecture compatible with implants from multiple manufacturers and supports patient-specific procedures. Used by orthopedic surgeons and hospitals performing total knee, unicompartmental knee, and total hip arthroplasty.
  • CUVIS-spine A spinal surgery robot system that provides precise guidance for pedicle screw insertion through preoperative image-based planning and real-time patient position tracking. Combines robotic accuracy with conventional surgical approaches to reduce surgical variability and radiation exposure. Used by neurosurgical and orthopedic spine surgery departments in hospitals.
  • MorningWalk A footplate-based end-effector gait rehabilitation robot designed for patients with lower-limb paralysis or gait impairments, including stroke, spinal cord injury, Parkinson's disease, and post-surgery recovery. Offers shorter setup times and varied gait training patterns compared to exoskeleton systems, and includes propulsion feedback training for active gait training. Designed for both pediatric and adult populations. Used by rehabilitation hospitals and physical therapy centers.

Quantifiable outcome

  • CUVIS-joint cumulative surgeries: 43,000+ cases across 9+ countries
  • +4 more outcomes

Companies that use Curexo

Customer profile

Named customers12 records

Segments4 records

Ideal customer profiles3 records

Curexo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Curexo partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core and minor.

  • Droguepar S.A.coreChannel Partner/ Reseller/ Distributor · 19 May 2026Paraguayan medical device company partnered for CUVIS-joint supply agreement, marking Curexo's entry into Paraguay market and expansion of Latin American footprint.
  • ARTIMEDICAcoreChannel Partner/ Reseller/ Distributor · 1 May 2026Mexican medical device company collaborating with Curexo for local sales and marketing of CUVIS-spine following COFEPRIS regulatory approval.
  • Permedica S.p.A.coreChannel Partner/ Reseller/ Distributor · 30 April 2026Italian orthopedic implant company (founded 1986) serves as distribution partner for CUVIS-joint in Italy and Morocco. Joint surgery demonstration at FM6SS Morocco showcased synergy between Curexo's bone cutting and Permedica's implants. Open platform strategy enables collaboration across implant manufacturers.
  • Korean Trade-Investment Promotion Agency (KOTRA)coreGTM or Marketing Partner · 1 April 2026KOTRA organized Korea-India Business Partnership Forum where Curexo participated to expand Indian market network. Forum held during bilateral summit schedule in New Delhi.
  • M&M BrazilminorChannel Partner/ Reseller/ Distributor · 1 April 2026Local partner for participation in CBCJ 2026 (Brazilian Knee Surgery Congress) in São Paulo, showcasing CUVIS-joint at booth #12.
  • CG Bio (시지바이오)coreChannel Partner/ Reseller/ Distributor · 27 March 2026Korean bio-regenerative medicine company signed exclusive domestic distribution agreement for CUVIS-spine. Partnership aims to expand in domestic and international spine surgery markets through robot-navigation-based platform.
  • SPG (Sangsang Precision Group)coreTechnology or Integration · 12 March 2026SPG signed MOU to supply precision actuators for Curexo's medical robots. Partnership aims to localize core components and enhance global competitiveness through custom actuator design, technical exchanges, and joint marketing activities.
  • OrthoHousecoreChannel Partner/ Reseller/ Distributor · 1 February 2026Egyptian partner company participating with Curexo at ITC 2026 (International Trauma Congress) in Dubai for MENA market expansion.
  • Indian SubsidiarycoreChannel Partner/ Reseller/ Distributor · 1 January 2026Curexo established Indian subsidiary for direct market presence and local network expansion in India's high-growth medical robotics market.
  • Harmonic BionicsminorChannel Partner/ Reseller/ Distributor · 1 April 2024US-based Harmonic Bionics partnered with Curexo to distribute the Morning Walk S200 gait rehabilitation system in the walking assist devices market.
  • Think Surgical Inc. (TSI)minorStrategic or Co-development Partner · 1 January 2024Partnership for AAOS 2024 exhibition where CUVIS-joint (US product name: TMAX) was showcased to US market.
  • Neuromeka (뉴로메카)coreTechnology or Integration · 1 January 2024Korean robot automation platform company partnered for supply of robot manipulators. Strategic partnership led to purchase agreement for 200 robot manipulators including trial production of CUVIS-joint robot arm prototypes.
  • AEGIS Spine Inc.minorChannel Partner/ Reseller/ Distributor · 1 January 2023US spine implant company distributing CUVIS-spine in United States market for spine surgery procedures.
  • Fourier IntelligencecoreChannel Partner/ Reseller/ Distributor · 1 August 2021Strategic global partnership for distribution of Morning Walk gait rehabilitation robot. Fourier's network spans 50+ countries including Singapore, Malaysia, Thailand, UK, Australia. Also exploring joint technology development for rehabilitation robotics.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Curexo competitors and assessment

Company assessment

Broad incumbents

  • Stryker (Mako): Stryker's Mako robotic-arm-assisted surgery system is the dominant robotic joint replacement platform globally, with thousands of installations and the largest US installed base. Directly comparable to CUVIS-joint in TKA/THA, though Stryker operates at vastly larger scale and with proprietary closed-platform integration.
  • Intuitive Surgical (da Vinci): Intuitive Surgical's da Vinci is the dominant general-surgery robotic platform globally with a vast installed base. While da Vinci does not directly compete in orthopedics, it defines the hospital robotic-surgery procurement landscape that CUVIS-joint and CUVIS-spine compete within.

Direct peers

  • Renishaw (Neuromate / neurosurgical robotics): Renishaw's neuromate robotic system targets stereotactic neurosurgery, sharing technological overlap with CUVIS-spine's image-guided pedicle screw placement. Both are precision-guided surgical robotic platforms competing for hospital surgical departments.
  • Globus Medical (ExcelsiusGPS): Globus Medical's ExcelsiusGPS is a leading robotic spine surgery platform with strong US hospital penetration. Directly comparable to CUVIS-spine, with similar navigation-and-arm integration approach; Globus pairs robotics with its own spine implant portfolio.
  • Medtronic (Mazor / Hugo): Medtronic's Mazor robotic guidance system is a market leader in spine robotics, directly competing with Curexo's CUVIS-spine for hospital spine surgery accounts. Medtronic also operates Hugo for general surgery, providing scale and breadth Curexo lacks.
  • Zimmer Biomet (ROSA): Zimmer Biomet's ROSA robotic system spans knee, hip, and spine indications, directly overlapping with Curexo's CUVIS-joint and CUVIS-spine portfolio. As one of the 'big five' orthopedic players, Zimmer Biomet competes on bundled implants and an established sales network.
  • Smith+Nephew (CORI): Smith+Nephew's CORI handheld robotic system targets robotic-assisted knee surgery with a compact, image-free design. Directly comparable to CUVIS-joint in surgical indication and target customer segment, though Smith+Nephew has a much broader orthopedic portfolio and established global salesforce.
  • THINK Surgical: THINK Surgical develops open-platform robotic systems for orthopedic surgery — architecturally aligned with Curexo's implant-agnostic CUVIS-joint strategy. Curexo has an existing partnership with TSI for AAOS exhibitions, and the two are direct competitors in open-platform orthopedic robotics.
  • Hocoma (rehabilitation robotics): Hocoma (a DIH Medical company) is a leading developer of robotic and sensor-based rehabilitation devices including gait-training systems. Directly comparable to Curexo's Morning Walk in end-effector gait rehabilitation for stroke and orthopedic patients.

Emerging players

  • Fourier Intelligence: Fourier Intelligence is a Chinese rehabilitation robotics company and Curexo's exclusive global distribution partner for Morning Walk. Overlapping product portfolio in gait-rehabilitation robotics makes it both a channel partner and a direct competitor in select end markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Curexo social profiles

Digital presence

Curexo compliance and trust

Trust signal

Compliance3 records

Curexo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Curexo leadership team

Management profile

Number of profiles

Profiles2 records

Curexo funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Curexo M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curexo

What does Curexo do?

Curexo designs, manufactures, and sells medical robotics systems for orthopedic surgery, spine surgery, and lower-limb rehabilitation. Its product portfolio includes the CUVIS-joint fully automated joint replacement surgery robot (knee and hip), the CUVIS-spine spinal surgery robot for pedicle screw guidance, and the MorningWalk end-effector gait rehabilitation robot. The company supplies these robots as capital equipment to hospitals and medical institutions globally, supported by installation, training, and after-sales services along with recurring surgical instrument and consumable sales.

Is Curexo a public or private company?

Curexo is a public company. It is classified as public and is currently operating.

When was Curexo founded?

Curexo was founded in 2017. It employs 51 to 100 people.

Where is Curexo based?

Curexo is headquartered in Seoul, South Korea, in the Asia region.

How does Curexo make money?

Three revenue lines are on record. Medical Robot Hardware Sales are the primary driver. The others are consumables and Surgical Instruments and service and Technical Support.

Who are Curexo's main competitors?

Broad incumbents on record are Stryker (Mako) and Intuitive Surgical (da Vinci). Direct peers are Renishaw (Neuromate / neurosurgical robotics), Globus Medical (ExcelsiusGPS), Medtronic (Mazor / Hugo), Zimmer Biomet (ROSA), Smith+Nephew (CORI), THINK Surgical and Hocoma (rehabilitation robotics). Fourier Intelligence is listed as an emerging player.

Does Curexo have an API?

No public API is recorded for Curexo.

What industry is Curexo in?

Curexo's product category is Medical Robotics Systems. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AsiaeSPG Signs MOU with CUREXO for Supply of Precision Actuators for Medical RobotsSPG and CUREXO signed an MOU on March 12 at CUREXO's Seoul headquarters for SPG to supply precision actuators for CUREXO's medical robots, with the goal of localizing core components and enhancing global competitiveness. Under the agreement, SPG will be the primary supplier of precision actuators optimized for CUREXO's medical robot specifications, and both companies will collaborate on custom actuator design, technical exchanges, and joint marketing activities. The partnership aims to advance localization efforts while strengthening the market position of both companies in the medical robotics sector.PR NewswireInnovative Medical Products & Curexo Inc. Announce Strategic OUS Distribution PartnershipInnovative Medical Products, Inc. (IMP) and Curexo Inc. announced a global strategic nonexclusive distribution partnership under which Curexo will bundle IMP's surgical positioning devices—including the De Mayo D2 Knee Positioner and De Mayo Universal Distractor 2.0—with its CUVIS-joint surgical robot for distribution in hospitals outside the U.S. and worldwide. IMP will retain its independent U.S. sales channel while the partnership enables both companies to offer combined robotic surgery solutions, a pairing Curexo reports has been used in over 16,000 total knee arthroplasty cases to date. The companies stated they also aim to develop new technology suited to Curexo's robotic surgery platform through this collaboration.Ortho Spine NewsInnovative Medical Products & Curexo Inc. Announce Strategic OUS Distribution PartnershipInnovative Medical Products and Curexo announced a global distribution partnership combining Curexo's CUVIS-joint surgical robot with IMP's De Mayo D2 Knee Positioner and Universal Distractor. The agreement covers hospitals outside the U.S., with IMP retaining independent U.S. sales. Curexo expects to develop new technology for its robotic surgery.PR NewswireCUREXO INC.'S ROBOTIC GAIT TRAINING SYSTEM, MORNING WALK S200, INSTALLED IN FIRST US INPATIENT REHABILITATION FACILITYHarmonic Bionics has completed the first US installation of Curexo's Morning Walk S200 robotic gait rehabilitation system at St. David's Rehabilitation Hospital in Austin, Texas, marking the first inpatient facility in the country to offer the technology. The FDA-registered system features virtual reality components, a saddle for weight support, and individual foot plates designed to facilitate natural walking patterns during gait training. The companies describe this as a major milestone validating the technology across different clinical settings in the American market.HarmonicbionicsHarmonic Bionics Enters into Strategic Partnership with Curexo Inc. and Completes First US Installation of End-effector Robotic Gait Rehab Device, Morning Walk S200Harmonic Bionics announced a strategic partnership with South Korean manufacturer Curexo Inc., which includes a $3 million investment and responsibilities for US promotion and business development. As part of this agreement, Harmonic Bionics completed the first US installation of Curexo’s Morning Walk S200 robotic gait rehabilitation system at Spero Rehab Clinic in Austin, Texas.PR NewswireCUREXOs Wirbelsäulenchirurgie-Roboter „CUVIS-spine" erhält die FDA-Zulassung (US)CUREXO Corp. announced on May 20, 2021 that its independently developed spinal surgery robot "CUVIS-spine" received FDA (US) licensing approval, following prior certifications in Korea (2019) and Europe CE (2020). The FDA clearance enables CUREXO to sell its medical robot in all countries, including the United States, which the company identifies as the largest medical market. CUREXO plans to expand its focus to global markets beyond Korea, targeting advanced medical markets like the USA and Europe with its portfolio of medical robots including CUVIS-joint, CUVIS-spine, and Morning Walk.PR NewswireEl robot de cirugía de columna de CUREXO, 'CUVIS-spine', obtiene la licencia de la FDA (EE. UU.)CUREXO Corp. announced on May 20, 2021, that its independently developed spinal surgery robot 'CUVIS-spine' has received FDA clearance from the United States, marking its third regulatory license following Korean (2019) and European CE (2020) certifications. The robot uses high-precision robotic arm technology with wireless one-step navigation to enable minimally invasive spinal surgery, reducing operation time and patient recovery duration compared to traditional manual procedures. CUREXO plans to leverage this FDA approval to expand sales of its medical robots, including CUVIS-spine, CUVIS-joint, and Morning Walk, into the US and other global advanced medical markets.The Korea HeraldCUREXO's spinal surgery robot, 'CUVIS-spine' acquired FDA (US) licensing.CUREXO's spinal surgery robot CUVIS-spine has acquired FDA licensing, enabling global supply. The robot reduces surgery duration and radiation exposure, with two units in use in Korea and one exported to Australia. CUREXO plans to expand sales to the US and Europe.PR NewswireCUREXO's spinal surgery robot, 'CUVIS-spine' acquired FDA (US) licensing.South Korean medical robot specialist CUREXO Corp. announced that its independently developed spinal surgery robot 'CUVIS-spine' has received FDA (US) licensing, the third regulatory approval following Korea (2019) and Europe CE (2020) certifications, enabling global distribution. The company currently has 3 units deployed—2 at Severance Hospital in Korea and 1 exported to an Australian medical facility—with plans to expand into the US and European markets. CEO Jae-Joon Lee emphasized that the FDA approval opens access to the world's largest medical market alongside existing sales in Korea and Europe.